Type I interferons affect the metabolic fitness of CD8+ T cells from patients with systemic lupus erythematosus.
Norzawani BuangLunnathaya TapengVictor GrayAlessandro SardiniChad WhildingLiz LightstoneThomas D CairnsMatthew C PickeringJacques BehmoarasGuang-Sheng LingMarina BottoPublished in: Nature communications (2021)
The majority of patients with systemic lupus erythematosus (SLE) have high expression of type I IFN-stimulated genes. Mitochondrial abnormalities have also been reported, but the contribution of type I IFN exposure to these changes is unknown. Here, we show downregulation of mitochondria-derived genes and mitochondria-associated metabolic pathways in IFN-High patients from transcriptomic analysis of CD4+ and CD8+ T cells. CD8+ T cells from these patients have enlarged mitochondria and lower spare respiratory capacity associated with increased cell death upon rechallenge with TCR stimulation. These mitochondrial abnormalities can be phenocopied by exposing CD8+ T cells from healthy volunteers to type I IFN and TCR stimulation. Mechanistically these 'SLE-like' conditions increase CD8+ T cell NAD+ consumption resulting in impaired mitochondrial respiration and reduced cell viability, both of which can be rectified by NAD+ supplementation. Our data suggest that type I IFN exposure contributes to SLE pathogenesis by promoting CD8+ T cell death via metabolic rewiring.
Keyphrases
- cell death
- end stage renal disease
- systemic lupus erythematosus
- immune response
- dendritic cells
- chronic kidney disease
- oxidative stress
- ejection fraction
- newly diagnosed
- nk cells
- peritoneal dialysis
- regulatory t cells
- disease activity
- signaling pathway
- physical activity
- rheumatoid arthritis
- dna methylation
- endoplasmic reticulum
- cell cycle arrest
- transcription factor
- single cell
- patient reported outcomes
- big data